Sigachi Industries (NSE:SIGACHI, BOM:543389) opened a new research and development center in Hyderabad, India, aimed at strengthening its active pharmaceutical ingredient (API) pipeline and analytical capabilities, according to a Wednesday filing on the Indian bourses.
The company said it plans to invest up to $1 million in the facility to support the development of priority APIs and complex intermediates for global markets.